[go: up one dir, main page]

PT81885B - Processo para a preparacao de composicoes farmaceuticas contendo uma combinacao sinergetica de flupirtina e antiflogisticos nao esteroides - Google Patents

Processo para a preparacao de composicoes farmaceuticas contendo uma combinacao sinergetica de flupirtina e antiflogisticos nao esteroides

Info

Publication number
PT81885B
PT81885B PT81885A PT8188586A PT81885B PT 81885 B PT81885 B PT 81885B PT 81885 A PT81885 A PT 81885A PT 8188586 A PT8188586 A PT 8188586A PT 81885 B PT81885 B PT 81885B
Authority
PT
Portugal
Prior art keywords
flupirtin
antiflogistics
steroid
pharmaceutical compositions
compositions containing
Prior art date
Application number
PT81885A
Other languages
English (en)
Other versions
PT81885A (de
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Publication of PT81885A publication Critical patent/PT81885A/pt
Publication of PT81885B publication Critical patent/PT81885B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PT81885A 1985-01-23 1986-01-22 Processo para a preparacao de composicoes farmaceuticas contendo uma combinacao sinergetica de flupirtina e antiflogisticos nao esteroides PT81885B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3502005 1985-01-23

Publications (2)

Publication Number Publication Date
PT81885A PT81885A (de) 1986-02-01
PT81885B true PT81885B (pt) 1987-11-30

Family

ID=6260451

Family Applications (1)

Application Number Title Priority Date Filing Date
PT81885A PT81885B (pt) 1985-01-23 1986-01-22 Processo para a preparacao de composicoes farmaceuticas contendo uma combinacao sinergetica de flupirtina e antiflogisticos nao esteroides

Country Status (15)

Country Link
US (1) US4778799A (pt)
EP (1) EP0189788B1 (pt)
JP (1) JPH0623103B2 (pt)
AT (1) ATE46265T1 (pt)
AU (1) AU574557B2 (pt)
CA (1) CA1259260A (pt)
DD (1) DD244293A5 (pt)
DE (1) DE3665538D1 (pt)
DK (1) DK30486A (pt)
ES (1) ES8705762A1 (pt)
FI (1) FI860304A7 (pt)
GR (1) GR860178B (pt)
HU (1) HUT39603A (pt)
PT (1) PT81885B (pt)
ZA (1) ZA86481B (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
IN172468B (pt) * 1990-07-14 1993-08-14 Asta Medica Ag
DK0560092T3 (da) * 1992-03-11 1998-08-10 Asta Medica Ag Tabletter, granulater og pellets med højt indholdaf aktivstoffer til højkoncentrerede, faste administreringsformer
DE4319649A1 (de) * 1993-03-18 1994-09-22 Asta Medica Ag Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
JP2920451B2 (ja) * 1993-03-29 1999-07-19 エスエス製薬株式会社 消炎鎮痛貼付剤
HUP0301296A2 (hu) * 1999-08-03 2003-08-28 Awd.Pharma Gmbh & Co. Kg Flupirtin alkalmazása degeneratív ízületi fájdalom kezelésére
MXPA03009484A (es) * 2001-04-17 2004-02-12 Tanabe Seiyaku Co Agente preventivo/de remedio para enfermedades inflamatorias en la mucosa de la cavidad oral y lo similar.
DE10328260A1 (de) * 2003-06-23 2005-01-27 Schmidt, K.-G., Dr. med. Flupirtine-Präparat
US20050089559A1 (en) 2003-10-23 2005-04-28 Istvan Szelenyi Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
DE10359335A1 (de) * 2003-10-23 2005-05-25 Viatris Gmbh & Co. Kg Kombinationen aus Kaliumkanalöffnern und Natriumkanalinhibitoren oder Natriumkanal beeinflussenden Wirkstoffen zur Behandlung von Schmerzzuständen
CA2550023C (en) * 2003-12-16 2011-04-12 Cnsbio Pty Ltd Treatment of neuropathic pain
US7960436B2 (en) * 2006-06-05 2011-06-14 Valeant Pharmaceuticals International Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators
AU2007288253B2 (en) 2006-08-23 2013-05-02 Xenon Pharmaceuticals Inc. Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
US8993593B2 (en) 2006-08-23 2015-03-31 Valeant Pharmaceuticals International N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
US8722929B2 (en) 2006-10-10 2014-05-13 Valeant Pharmaceuticals International N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
BRPI0719590A2 (pt) * 2006-11-28 2014-01-21 Valeant Pharmaceuticals Int Análogos de retigabina 1,4 diamino bicíclica como modulares de canal de potássio
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
US8367684B2 (en) 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
US8563566B2 (en) 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
US7786146B2 (en) * 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
WO2011102460A1 (ja) * 2010-02-19 2011-08-25 学校法人関西医科大学 胃潰瘍の予防又は治療剤、経口投与薬、及び胃潰瘍の予防又は治療剤の製造方法
DE102010063609A1 (de) * 2010-12-20 2012-06-21 Awd.Pharma Gmbh & Co. Kg Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3yl)-carbamidsäureethylester und einer Arylpropionsäure
DE102010063612A1 (de) * 2010-12-20 2012-06-21 Awd.Pharma Gmbh & Co. Kg Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamidsäureethylester und 2-[2-[(2,6-Dichlorphenyl)-amino]-phenyl]-essigsäure
US9320729B2 (en) 2012-05-18 2016-04-26 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
US20130310385A1 (en) 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants
US9855286B2 (en) 2012-05-18 2018-01-02 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component
US20130310435A1 (en) 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol
TWI886158B (zh) 2019-10-10 2025-06-11 加拿大商再諾製藥公司 選擇性鉀通道調節劑之固態晶型
KR20220098746A (ko) 2019-11-08 2022-07-12 제논 파마슈티칼스 인크. 우울 장애 치료 방법
IL304920A (en) 2021-02-09 2023-10-01 Xenon Pharmaceuticals Inc A voltage-gated potassium channel opener for use in the treatment of anhedonia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1211374A (en) * 1982-05-14 1986-09-16 Eszter Cholnoky Pharmaceutical compositions containing more active ingredients
EP0110091B1 (de) * 1982-10-27 1987-01-21 Degussa Aktiengesellschaft 2-Amino-3-Acylamino-6-benzylamino-pyridin-Derivate mit anti-epileptischer Wirkung
US4447443A (en) * 1982-11-15 1984-05-08 Merck & Co., Inc. Anti-inflammatory/analgesic combination of α-fluoromethylhistidine and a selected non-steroidal anti-inflammatory drug (NSAID)

Also Published As

Publication number Publication date
ES8705762A1 (es) 1987-05-16
JPH0623103B2 (ja) 1994-03-30
EP0189788A1 (de) 1986-08-06
FI860304L (fi) 1986-07-24
FI860304A0 (fi) 1986-01-22
HUT39603A (en) 1986-10-29
AU5260486A (en) 1986-07-31
ATE46265T1 (de) 1989-09-15
JPS61172819A (ja) 1986-08-04
CA1259260A (en) 1989-09-12
DK30486A (da) 1986-07-24
DE3665538D1 (en) 1989-10-19
FI860304A7 (fi) 1986-07-24
ZA86481B (en) 1986-10-29
PT81885A (de) 1986-02-01
EP0189788B1 (de) 1989-09-13
DK30486D0 (da) 1986-01-21
GR860178B (en) 1986-05-23
US4778799A (en) 1988-10-18
AU574557B2 (en) 1988-07-07
DD244293A5 (de) 1987-04-01
ES551119A0 (es) 1987-05-16

Similar Documents

Publication Publication Date Title
PT81885B (pt) Processo para a preparacao de composicoes farmaceuticas contendo uma combinacao sinergetica de flupirtina e antiflogisticos nao esteroides
PT90175A (pt) Processo para preparacao de derivados de gem-difosfonato substituidos por fenol e de composicoes farmaceuticas que os contem
PT83013B (pt) Processo para a preparacao de hidroxialquilxantinas terciarias, e de composicoes farmaceuticas que as contem
PT91158A (pt) Processo para a preparacao de novos estirenos e carboxamidas heterociclicos biciclicos e composicoes farmaceuticas que os contem
PT96438A (pt) Processo para preparacao de anti-oxidante lipideo-selectivos e de composicoes farmaceuticas que os contem
PT81007B (pt) Processo para a preparacao de derivados de 1,2-benzoisotiazolil-3-piperazina com accao analgesica e de composicoes farmaceuticas que os contem
PT89661A (pt) Processo para a preparacao de compostos pirrolicos substituidos e de composicoes farmaceuticas que os contem
PT98369A (pt) Processo para a preparacao de azois substituidos e de composicoes farmaceuticas que os contem
PT83143B (pt) Processo para a preparacao de 1,4-dihidro-piridinas 2-substituidas com tiometilo e de composicoes farmaceuticas que as contem
PT89094A (pt) Processo para a preparacao de 1-aril-3-quinolina-e 1-aril-3-isoquinolina-carboxamidas e de composicoes farmaceuticas que as contem
PT88203A (pt) Processo para a preparacao de quinolonas e de composicoes farmaceuticas que as contem
PT82066B (pt) Processo para preparacao de composicoes farmaceuticas contendo uma combinacao de flupirtina e de espasmoliticos com accao anticolinergica
PT82147B (pt) Processo para a preparacao de compostos com efeito inibitorio da 5-lipoxigenase e de composicoes farmaceuticas que os contem
PT82414B (pt) Processo para a preparacao de agentes bactericidas a base de 5,6-difluoronaftiridinas e de 5,6,8-difluoroquinolinas e de composicoes farmaceuticas que os contem
MX9201058A (es) Derivados ciclicos de cetal, procedimiento para supreparacion y composicion farmaceutica que los contiene.
PT83559B (pt) Processo para a preparacao de novos derivados de indol e indazol-ceto-sulfona e de composicoes farmaceuticas que os contem
PT89486A (pt) Processo para a preparacao de derivados 16-de-hidro de vitamina d3 e de composicoes farmaceuticas que os contem
PT90017A (pt) Processo para a preparacao de derivados de arilpiperazinilalcoxi de imidas ciclicas e de uma composicao farmaceutica que os contem
PT84358B (pt) Processo para a preparacao de naftotiazepinonas e de composicoes farmaceuticas que as contem
PT84023B (pt) Processo para a preparacao de novos derivados da 1-benzeno-sulfonil-2-oxo-alcoxi-pirrolidina e de composicoes farmaceuticas que os contem
PT98816A (pt) Processo para a preparacao de tienodiazepinas e de composicoes farmaceuticas que as contem
PT82855B (pt) Processo para a preparacao de glucopiranoses fosfonatos substituidos e de composicoes farmaceuticas que os contem
PT87942A (pt) Processo para a preparacao de benzimidazois substituidos e de composicoes farmaceuticas que os contem
PT90664A (pt) Processo para a preparacao de 2-aminotiazois substituidos e de composicoes farmaceuticas que os contem
PT89035A (pt) Processo para a preparacao de novos derivados da cisteina e de composicoes farmaceuticas que os contem

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19961130